ArticleMelanoma research2017

MGMT methylation correlates with melphalan pelvic perfusion survival in stage III melanoma patients: a pilot study.

Stefano Guadagni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.